Incomplete Kawasaki disease in a patient with chronic granulomatous disease.
Muneuchi
Jun
J
Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. mune@pediatr.med.kyushu-u.ac.jp
Ishimura
Masataka
M
Takada
Hidetoshi
H
Hoshina
Takayuki
T
Utsunomiya
Rina
R
Ikeda
Kazuyuki
K
Yamaguchi
Kenichiro
K
Ohga
Shouichi
S
Kusuhara
Koichi
K
Hara
Toshiro
T
D001241:Aspirin / Q000627:therapeutic use; D002675:Child, Preschool; D003323:Coronary Aneurysm / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D017023:Coronary Angiography; D004176:Dipyridamole / Q000627:therapeutic use; D005500:Follow-Up Studies; D006105:Granulomatous Disease, Chronic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D008991:Monitoring, Physiologic; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications* / Q000151:congenital / Q000175:diagnosis / Q000188:drug therapy; D018570:Risk Assessment; D012720:Severity of Illness Index; D013997:Time Factors
D016756:Immunoglobulins, Intravenous; D004176:Dipyridamole; D001241:Aspirin